載入...
High-Content Assay Multiplexing for Toxicity Screening in Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Hepatocytes
Cell-based high-content screening (HCS) assays have become an increasingly attractive alternative to traditional in vitro and in vivo testing in pharmaceutical drug development and toxicological safety assessment. The time- and cost-effectiveness of HCS assays, combined with the organotypic nature o...
Na minha lista:
| 發表在: | Assay Drug Dev Technol |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Mary Ann Liebert, Inc.
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4652224/ https://ncbi.nlm.nih.gov/pubmed/26539751 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/adt.2015.659 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|